IDO1 and cancer: Specular to this perspective – but relevant to targeted drug delivery strategies in IDO1-related contexts (i.e., cancer immunotherapy) – is a recent report illustrating how reprogrammed IDO-induced immunosuppressive microenvironment synergizes with immunogenic magnetothermodynamics for improved cancer therapy.